€18.90
2.39% today
L&S, Jul 02, 06:58 pm CET
ISIN
US09062W2044
Symbol
BLFS

BioLife Solutions, Inc. Share price

$20.79
-0.47 2.21% 1M
+4.54 27.94% 6M
+4.54 27.94% YTD
-0.71 3.30% 1Y
-23.87 53.45% 3Y
+3.40 19.55% 5Y
+18.53 819.91% 10Y
Nasdaq, Closing price Mon, Jul 01 2024
-0.64 2.99%
ISIN
US09062W2044
Symbol
BLFS
Sector

Key metrics

Market capitalization $957.77m
Enterprise Value $953.43m
PER (TTM) P/E ratio negative
EV/FCF (TTM) EV/FCF negative
EV/Sales (TTM) EV/Sales 6.94
P/S ratio (TTM) P/S ratio 6.98
P/B ratio (TTM) P/B ratio 2.85
Sales growth (TTM) Sales growth -15.89%
Turnover (TTM) Turnover $137.30m
EBIT (operating result TTM) EBIT $-54.54m
Free cash flow (TTM) Free cash flow $-17.70m
Cash position $45.30m
EPS (TTM) EPS $-1.43
P/E ratio expected negative
P/S ratio expected 8.87
EV/Sales expected 8.83
Short interest 13.45%
Show more

Is BioLife Solutions, Inc. a top scorer stock according to the dividend, high growth investing or Leverman strategy?

As a free StocksGuide basic user, you can view the scores for all 6,954 shares worldwide.

BioLife Solutions, Inc. Share analysis

Unlock Scores for Free

Analyst opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

9x Buy
100%

Analyst opinions

9 Analysts have issued a BioLife Solutions, Inc. forecast:

Buy
100%

Financial data from BioLife Solutions, Inc.

Mar '24
+/-
%
Net profit -63 -63
57% 57%
-46%
Depreciation and amortization 11 11
38% 38%
8%
Share compensation 30 30
12% 12%
22%
Operating cash flow -14 -14
335% 335%
-10%
Investments 3.44 3.44
72% 72%
3%
Dividend paid - -
-
-
Free cash flow -18 -18
14% 14%
-13%

Figures in millions USD.

Don't miss a thing! We will send you all news about the BioLife Solutions, Inc. share directly to your mailbox free of charge.

If you wish, you can receive an e-mail every morning in time for breakfast containing all the stock news relevant to you.

BioLife Solutions, Inc. Share News

Neutral
PRNewsWire
about one month ago
New container developed for the needs of cell and gene therapy (CGT) primary packaging to replace cryopreservation bags with a fracture resistant, rigid construction built for both manual use and closed-system automation. BOTHELL, Wash.
Neutral
Seeking Alpha
about 2 months ago
Start Time: 16:30 January 1, 0000 5:02 PM ET BioLife Solutions, Inc. (NASDAQ:BLFS ) Q1 2024 Earnings Conference Call May 09, 2024, 16:30 PM ET Company Participants Rod de Greef - Chairman and CEO Troy Wichterman - CFO Garrie Richardson - Chief Revenue Officer Conference Call Participants Paul Knight - KeyBanc Hannah Hefley - Stephen Inc. Matthew Stanton - Jefferies Matt Hewitt - Craig-Hallum Ca...
Neutral
PRNewsWire
about 2 months ago
Cell Processing revenue increased 10% sequentially to $16.2 million GAAP gross margin of 38%  and net loss of $10.2 million Non-GAAP adjusted gross margin expands from 40%  to 53%  and adjusted EBITDA of $3.6 million  or 13% ex-GCI freezers Conference call begins at 4:30 p.m. Eastern time today   BOTHELL, Wash.
More BioLife Solutions, Inc. News

Company profile

BioLife Solutions, Inc. engages in the development, manufacture, and marketing of biopreservation tools for cells and tissues. Its product offerings include proprietary hypothermic storage and cryopreservation freeze media products for cells, tissues, and organs; generic blood stem cell freezing and cell thawing media products; and custom product formulation and custom packaging services. The company was founded by Boris Rubinsky in 1998 and it is headquartered in Bothell, WA.

Head office United States
CEO Roderick Greef
Employees 414
Founded 1987
Website www.biolifesolutions.com

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today